Frontier Capital Management CO LLC Tg Therapeutics, Inc. Transaction History

Frontier Capital Management CO LLC

  • $9.96 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022
SELL
$3.74 - $10.66 $2.31 Million - $6.6 Million
-618,821 Closed
0 $0
Q1 2022

Apr 14, 2022
BUY
$7.81 - $20.45 $3.61 Million - $9.45 Million
462,203 Added 295.11%
618,821 $5.89 Million
Q4 2021

Jan 19, 2022
BUY
$15.2 - $35.51 $2.38 Million - $5.56 Million
156,618 New
156,618 $2.98 Million

Others Institutions Holding TGTX

# of Institutions
338
Shares Held
87.7M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.68B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Frontier Capital Management CO LLC Portfolio

Follow Frontier Capital Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email